Regulus Therapeutics stock soars on acquisition deal with Novartis
-- Regulus (NASDAQ:RGLS) Therapeutics shares skyrocketed today, posting a 133.5% gain following the announcement of...
-- Regulus (NASDAQ:RGLS) Therapeutics shares skyrocketed today, posting a 133.5% gain following the announcement of...
-- Prada Group reported a strong start to 2025, with first-quarter net revenues rising 13% year-over-year to €1.34...
-- Barclays has lowered its price target on Apple to $173, implying a downside of nearly 20% from the stock’s last...
(Reuters) -Some non-U.S. companies have said they are looking at expanding their presence or setting up shop in the United States...
By David Shepardson WASHINGTON (Reuters) -U.S. House Republicans will propose dropping a $20 federal annual registration fee on...
By Foo Yun Chee BRUSSELS (Reuters) -Microsoft respects European laws including landmark legislation which seeks to rein in the...
-- Genus (LON:GNS), the British animal genetics company, saw its stock price leap nearly 30% to 2,055p, making it...
-- China Investment Corporation (CIC), a Chinese sovereign investor, is planning to sell approximately $1 billion of...
By Giulio Piovaccari and Gilles Guillaume MILAN (Reuters) -Stellantis on Wednesday suspended its guidance for a moderate recovery...
By Casey Hall and Sophie Yu SHANGHAI (Reuters) -New Disney (NYSE:DIS) movie Thunderbolts* is poised to test Chinese appetite...